Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yakoob Vallie

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|June 7, 2011
The great pretenderSean Wasserman, Yakoob Vallie, Alan Bryer
Antimicrobial Agents and Chemotherapy|May 11, 2021
Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled TrialSean Wasserman, Angharad Davis, Cari Stek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 9, 2022
A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis: The LASER-TBM TrialAngharad G Davis, Sean Wasserman, Cari Stek, et al.
Wellcome Open Research|July 21, 2021
Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]Angharad G Davis, Sean Wasserman, Mpumi Maxebengula, et al.
Trials|May 9, 2024
Testing novel strategies for patients hospitalised with HIV-associated disseminated tuberculosis (NewStrat-TB): protocol for a randomised controlled trialPhiona E Namale, Linda Boloko, Marcia Vermeulen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|June 7, 2011
The great pretenderSean Wasserman, Yakoob Vallie, Alan Bryer
Antimicrobial Agents and Chemotherapy|May 11, 2021
Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled TrialSean Wasserman, Angharad Davis, Cari Stek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 9, 2022
A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis: The LASER-TBM TrialAngharad G Davis, Sean Wasserman, Cari Stek, et al.
Wellcome Open Research|July 21, 2021
Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]Angharad G Davis, Sean Wasserman, Mpumi Maxebengula, et al.
Trials|May 9, 2024
Testing novel strategies for patients hospitalised with HIV-associated disseminated tuberculosis (NewStrat-TB): protocol for a randomised controlled trialPhiona E Namale, Linda Boloko, Marcia Vermeulen, et al.
Pageof 1